Evidence map›Paper›PMID 42601187›Full record

ArticleJournal of medical genetics2026

Childhood-onset neurodegeneration and brain atrophy: defining

Amanda Nagy, Anna Luddy, Francine Molay, Haley McLaughlin, Lizbeth De La Rosa Abreu, Catherine Becker, Markus Terrey, Cathleen M Lutz, Anoopum Gupta, Florian S Eichler

Abstract read
In one paragraph

Article in Journal of medical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amanda NagyDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA anagy2@mgb.org.ORCID http://orcid.org/0000-0001-8116-4805
Anna LuddyDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Francine MolayDivision of Clinical Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Haley McLaughlinDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Lizbeth De La Rosa AbreuDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Catherine BeckerDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Markus TerreyRare Disease Translational Center, The Jackson Laboratory, Bar Harbor, Maine, USA.
Cathleen M LutzRare Disease Translational Center, The Jackson Laboratory, Bar Harbor, Maine, USA.
Anoopum Gupta *Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Florian S Eichler *Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Funding

The Mutant Mouse Resource and Research Center at The Jackson LaboratoryU42OD010921 · OD · JACKSON LABORATORY · PI Cathleen M Lutz · 2012 to 2026
$21.4M
The Jackson Laboratory Center for Precision GeneticsU54OD030187 · OD · JACKSON LABORATORY · PI Cathleen M Lutz, Stephen A Murray · 2020 to 2026
$17.2M
Validation of the GMFC-MLDU54NS115052 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Laura Ann Adang, FLORIAN S EICHLER · 2019 to 2026
$14.3M
Development of Real-World Motor Outcome Measures in Ataxia-TelangiectasiaR01NS134597 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Anoopum Satyawan Gupta · 2024 to 2026
$1.9M
NIH HHS U42 OD010921NIH HHS U54 OD030187NINDS NIH HHS R01 NS134597NINDS NIH HHS U54 NS115052
6 · The paper itself

Abstract

backgroundThe heterozygous variant c.628G>A (p.Glu210Lys) in

methodsCaregivers of individuals with CONDBA completed cross-sectional surveys detailing genetic, developmental and clinical features. Patients evaluated in a neurogenetics clinic underwent Brief Ataxia Rating Scale (BARS) assessments compared with remotely collected wrist and ankle accelerometry data. Neurofilament light chain (NFL) levels were assessed in the clinic cohort and in a Ubtf E210K knock-in mouse model.

resultsAll 11 caregiver surveys reported onset of neurodevelopmental regression (median 3.5 years, range 0.5-5 years), at times following anaesthesia or illness and 82% developed ataxia. Motor activity data from five participants (median 11.8 years, range 8.1-12.5 years) had high test-retest reliability, correlated with ataxia severity as measured by the BARS, and showed declines across multiple measures over the study period. NFL was abnormally elevated in both humans and the mouse model.

conclusion

Indexed as

Central Nervous System DiseasesCerebellar DiseasesMovement DisordersNeurodegenerative DiseasesPediatrics

Identifiers

PMID42601187
PMCPMC13614006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.